MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

QPS over the supplementary motor area induced cortical excitability changes in human primary motor cortex: Comparison with Placebo effect

K. Sato, M. Hamada, Y. Shirota, S. Kodama, Y. Sugiyama, Y. Ugawa, C. Hosoda, T. Toda (Tokyo, Japan)

Meeting: 2019 International Congress

Abstract Number: 1233

Keywords: Motor-evoked potential(MEP), Repetitive transcranial magnetic stimulation(rTMS)

Session Information

Date: Tuesday, September 24, 2019

Session Title: Neurophysiology

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: To explore the effects of quadripulse stimulation (QPS) over the supplementary motor area (SMA) in the healthy humans.

Background: Repetitive transcranial magnetic stimulation (rTMS) has been applied as a treatment of various neurologic diseases. In Parkinson disease (PD), some meta-analysis indicated that rTMS over the primary motor cortex (M1) or SMA improve motor symptoms. Both high frequency (HF) and low frequency (LF) rTMS improve the PD symptoms, but the effect of rTMS is highly variable among individuals. The interindividual variability of QPS was reported to be lower compared with other rTMS protocols, offering a potential of therapeutic use of QPS in PD. However, it is unclear whether QPS over SMA could indeed induce cortical excitability changes. Based on these, we assessed the effect of QPS over SMA in healthy individuals.

Method: Ten healthy volunteers (8 men, 2 women, mean age 28.9 ± 5.2 years) participated in this experiment. We evaluated motor-evoked potentials (MEPs), short interval intracortical inhibition (SICI) and intracortical facilitation (ICF) before and after QPS over left SMA. MEPs were recorded from the right first dorsal interosseous (FDI) muscle at rest. TMS pulse was set at intensity of 90% active motor threshold (AMT) for FDI. Interstimulus interval (ISI) was 5 or 50ms (QPS-5 or 50). Sham stimulation was performed as placebo. Participants received all rTMS patterns (QPS-5, QPS-50, and Sham stimulation) in random order at an interval of at least one week (washout time).

Results: QPS-50 induced MEP size reduction for 30min after the intervention. In contrast, neither QPS-5 nor sham stimulation induced any significant MEP changes. Neither SICI nor ICF was affected by any QPS interventions.

Conclusion: We, here, showed QPS over SMA induced heterotopic LTD like plasticity in the primary motor cortex (M1). In contrast, QPS over M1 induced bi-directional, homotopic plasticity in M1. The present results suggest that we should not simply extrapolate the results of rTMS over M1 to other cortical areas.

To cite this abstract in AMA style:

K. Sato, M. Hamada, Y. Shirota, S. Kodama, Y. Sugiyama, Y. Ugawa, C. Hosoda, T. Toda. QPS over the supplementary motor area induced cortical excitability changes in human primary motor cortex: Comparison with Placebo effect [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/qps-over-the-supplementary-motor-area-induced-cortical-excitability-changes-in-human-primary-motor-cortex-comparison-with-placebo-effect/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/qps-over-the-supplementary-motor-area-induced-cortical-excitability-changes-in-human-primary-motor-cortex-comparison-with-placebo-effect/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley